跳至主要内容
临床试验/NCT02173613
NCT02173613终止不适用

Reduction of the Duration of Antibiotic Guided by Procalcitonin in Infections Lungs of Hospitalized Elderly: a Randomized

University Hospital, Grenoble2 个研究点 分布在 1 个国家目标入组 117 人开始时间: 2012年8月1日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
117
试验地点
2
主要终点
Duration of antibiotic therapy

研究概览

简要总结

The main objective is to evaluate the interest of the repeated measurement of procalcitonin in patients with pulmonary infection to reduce the duration of antibiotic therapy in comparison with a conventional clinical strategy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
80 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 80 years
  • Started antibiotics for a chest infection
  • Procalcitonin performed J0 antibiotic treatment
  • Person affiliated to the social security

排除标准

  • Patients with a documented infection with germs after Listeria spp, Legionella pneumophilia, Mycobacterium tuberculosis
  • Patients with a documented infection with a virus or parasite (eg hemorrhagic fever, malaria)
  • Patients with endovascular infection associated (endocarditis, pacemaker. Intravascular catheter)
  • Patients with lung abscess associated upon entry Patients with a chronic infection associated
  • Patients with severe immunosuppression (HIV or transplant)
  • Palliative patient
  • Death within 24 hours of admission to nursing units.
  • Presence of antibiotic treatment for chronic infection.
  • Patient under guardianship, curatorship or any other administrative or judicial action or deprivation of the right or freedom
  • Patients hospitalized without their consent

结局指标

主要结局

Duration of antibiotic therapy

时间窗: Success of antibiotic therapy within 45 days of inclusion

次要结局

未报告次要终点

研究者

发起方
University Hospital, Grenoble
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验